Are we really that blind?

Journal of Biopharmaceutical Statistics

Volumn 15, Issue 3, 2005, Pages 479-489

  Van Der Meulen, Egbert A ^a  

^a NV Organon   (Netherlands)

Author keywords

Blinded inference; Maximum likelihood; Mixture distributions; Normal distribution; Randomly permuted blocks

Indexed keywords

ACCURACY; ARTICLE; CALCULATION; DOUBLE BLIND PROCEDURE; DRUG INDUSTRY; MATHEMATICAL ANALYSIS; PHARMACEUTICS; PRIORITY JOURNAL; RANDOMIZATION; SAMPLE SIZE; STATISTICAL ANALYSIS; STATISTICAL MODEL;

ALGORITHMS; DATA INTERPRETATION, STATISTICAL; DOUBLE-BLIND METHOD; RANDOMIZED CONTROLLED TRIALS; REPRODUCIBILITY OF RESULTS; RESEARCH DESIGN;

EID: 18744386391     PISSN: 10543406     EISSN: None     Source Type: Journal    
DOI: 10.1081/BIP-200056540     Document Type: Article

References (9)

1. Berger, V. W., Ivanova, A., Knoll, M. D. (2003). Minimizing predictability while retaining balance through the use of less restrictive randomization procedures. Stat. Med. 22:3017-3028.
2. Echt, D. S., Liebson, P. R., Mitchell, L. B., Peters, R. W., Obias-Manno, D., Barker, A. H., Arensberg, D., Baker, A., Friedman, L., Greene, H. L., Huther, M. L., Richardson, M. W., and the CAST investigators. (1991). Mortality and morbidity in patients receiving encainide, flrcaonide, or placebo. The Cardiac Arrhytmia Suppression Trial. N. Engl. J. Med. 324:781-788.
3. Ellenberg, S. S., Fleming, T. R., DeMets, D. L. (2002). Data Monitoring Committees in Clinical Trials. A Practical Perspective. Chichester: John Wiley & Sons.
4. Gould, A. L., Shih, W. J. (1992). Sample size re-estimation without unblinding for normally distributed outcomes with unknown variance. Commun. Statist. Theory Meth. 21(10):2833-2853.
5. ICH. (1998). Topic E9 (Step 4, Consensus guideline, 5.2.98). Statistical Principles for Clinical Trials. htpp://www.fda.gov/cder/guidance/index.htm
6. Kalish, L. A., Begg, C. B. (1985). Treatment allocation methods in clinical trials: A review. Stat. Med. 4:129-144.
7. McEntegart, D. J. (2003). The pursuit of balance using stratified and dynamic randomization techniques: An overview. Drug Info. J. 37:293-308.
8. Shih, W. J. (1992). Sample size reestimation in clinical trials. In: Peace, K., ed. Biopharmaceutical Sequential Statistical Applications. New York: Marcel Dekker, pp. 285-301.
9. Shih, W. J. (1993). Sample size reestimation for triple blind clinical trials. Drug Info. J. 27:761-764.